Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.
This article is from
The Cancer Letter
archive.
Vol. 31 No. 35 | September 30, 2005
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Wynder, Doll, Hill Share Ochsner Award
September 23, 1988
TCL Archive
Analysis Shows No Mortality Benefit From Regular PSA Screening
January 27, 2012
TCL Archive
Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’
May 3, 1991
TCL Archive
Arimidex Gets Full Approval For HR+ Early Breast Cancer
September 30, 2005
TCL Archive
NCI awards $42 million for prevention trials consortium.
December 5, 2003
TCL Archive
Letters To the Editor: Blumenthal Coverage Called “Destructive”
November 14, 1997